Adela is a healthcare technology company that specializes in blood testing for early cancer detection and minimal residual disease monitoring using a genome-wide methylome enrichment platform.

Grit Biotechnology is a Shanghai-based cell therapy company that develops transformative cancer treatments, focusing on the development of Tumor-Infiltrating Lymphocyte (TIL) products and gene-edited TIL therapies.

Cellares is an integrated development and manufacturing organization that accelerates access to life-saving cell therapies by automating the entire manufacturing process through its Cell Shuttle platform and Smart Factories.